120 related articles for article (PubMed ID: 20553052)
1. Effect of clozapine on neutrophil kinetics in rabbits.
Iverson S; Kautiainen A; Ip J; Uetrecht JP
Chem Res Toxicol; 2010 Jul; 23(7):1184-91. PubMed ID: 20553052
[TBL] [Abstract][Full Text] [Related]
2. Clozapine bioactivation induces dose-dependent, drug-specific toxicity of human bone marrow stromal cells: a potential in vitro system for the study of agranulocytosis.
Pereira A; Dean B
Biochem Pharmacol; 2006 Sep; 72(6):783-93. PubMed ID: 16844094
[TBL] [Abstract][Full Text] [Related]
3. Effect of clozapine and olanzapine on neutrophil kinetics: implications for drug-induced agranulocytosis.
Ng W; Kennar R; Uetrecht J
Chem Res Toxicol; 2014 Jul; 27(7):1104-8. PubMed ID: 24968069
[TBL] [Abstract][Full Text] [Related]
4. Testing the hypothesis that selenium deficiency is a risk factor for clozapine-induced agranulocytosis in rats.
Ip J; Uetrecht JP
Chem Res Toxicol; 2008 Apr; 21(4):874-8. PubMed ID: 18380444
[TBL] [Abstract][Full Text] [Related]
5. Predicting drug-induced agranulocytosis: characterizing neutrophil-generated metabolites of a model compound, DMP 406, and assessing the relevance of an in vitro apoptosis assay for identifying drugs that may cause agranulocytosis.
Iverson S; Zahid N; Uetrecht JP
Chem Biol Interact; 2002 Nov; 142(1-2):175-99. PubMed ID: 12399162
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis.
Williams DP; Pirmohamed M; Naisbitt DJ; Maggs JL; Park BK
J Pharmacol Exp Ther; 1997 Dec; 283(3):1375-82. PubMed ID: 9400013
[TBL] [Abstract][Full Text] [Related]
7. Increased apoptosis of neutrophils in a case of clozapine-induced agranulocytosis - a case report.
Loeffler S; Fehsel K; Henning U; Fischer J; Agelink M; Kolb-Bachofen V; Klimke A
Pharmacopsychiatry; 2003 Jan; 36(1):37-41. PubMed ID: 12649775
[TBL] [Abstract][Full Text] [Related]
8. Effect of aminoglutethimide on neutrophils in rats: implications for idiosyncratic drug-induced blood dyscrasias.
Ng W; Uetrecht J
Chem Res Toxicol; 2013 Aug; 26(8):1272-81. PubMed ID: 23889370
[TBL] [Abstract][Full Text] [Related]
9. Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells.
Liu ZC; Uetrecht JP
J Pharmacol Exp Ther; 1995 Dec; 275(3):1476-83. PubMed ID: 8531118
[TBL] [Abstract][Full Text] [Related]
10. The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man.
Maggs JL; Williams D; Pirmohamed M; Park BK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1463-75. PubMed ID: 8531117
[TBL] [Abstract][Full Text] [Related]
11. Clozapine promotes the proliferation of granulocyte progenitors in the bone marrow leading to increased granulopoiesis and neutrophilia in rats.
Lobach AR; Uetrecht J
Chem Res Toxicol; 2014 Jul; 27(7):1109-19. PubMed ID: 24968143
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of clozapine by neutrophils. Possible implications for clozapine-induced agranulocytosis.
Uetrecht JP
Drug Saf; 1992; 7 Suppl 1():51-6. PubMed ID: 1503678
[TBL] [Abstract][Full Text] [Related]
13. Testing the hypothesis that vitamin C deficiency is a risk factor for clozapine-induced agranulocytosis using guinea pigs and ODS rats.
Ip J; Wilson JX; Uetrecht JP
Chem Res Toxicol; 2008 Apr; 21(4):869-73. PubMed ID: 18380445
[TBL] [Abstract][Full Text] [Related]
14. Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine.
Williams DP; Pirmohamed M; Naisbitt DJ; Uetrecht JP; Park BK
Mol Pharmacol; 2000 Jul; 58(1):207-16. PubMed ID: 10860943
[TBL] [Abstract][Full Text] [Related]
15. Potential role of a quetiapine metabolite in quetiapine-induced neutropenia and agranulocytosis.
Li X; Cameron MD
Chem Res Toxicol; 2012 May; 25(5):1004-11. PubMed ID: 22506851
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the oxidation of clozapine and olanzapine to reactive metabolites and the toxicity of these metabolites to human leukocytes.
Gardner I; Zahid N; MacCrimmon D; Uetrecht JP
Mol Pharmacol; 1998 Jun; 53(6):991-8. PubMed ID: 9614200
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic activity in serum of patients with clozapine-induced agranulocytosis.
Pisciotta AV; Konings SA; Ciesemier LL; Cronkite CE; Lieberman JA
J Lab Clin Med; 1992 Mar; 119(3):254-66. PubMed ID: 1541875
[TBL] [Abstract][Full Text] [Related]
18. The cytotoxicity of clozapine metabolites: implications for predicting clozapine-induced agranulocytosis.
Tschen AC; Rieder MJ; Oyewumi LK; Freeman DJ
Clin Pharmacol Ther; 1999 May; 65(5):526-32. PubMed ID: 10340918
[TBL] [Abstract][Full Text] [Related]
19. Increased FasL expression correlates with apoptotic changes in granulocytes cultured with oxidized clozapine.
Husain Z; Almeciga I; Delgado JC; Clavijo OP; Castro JE; Belalcazar V; Pinto C; Zuñiga J; Romero V; Yunis EJ
Toxicol Appl Pharmacol; 2006 Aug; 214(3):326-34. PubMed ID: 16510162
[TBL] [Abstract][Full Text] [Related]
20. Bioactivation and covalent binding of hydroxyfluperlapine in human neutrophils: implications for fluperlapine-induced agranulocytosis.
Lai WG; Gardner I; Zahid N; Uetrecht JP
Drug Metab Dispos; 2000 Mar; 28(3):255-63. PubMed ID: 10681368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
